Citation Impact
Citing Papers
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
2018 Standout
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation
2008
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
2009 Standout
Activation of Inward Rectifier Potassium Channels Accelerates Atrial Fibrillation in Humans
2006
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: Study Rationale and Design
2018
Catheter Ablation for Atrial Fibrillation in Patients With Left Ventricular Systolic Dysfunction. A Systematic Review and Meta-Analysis
2011
Accelerometer‐Derived Time Intervals during Various Pacing Modes in Patients with Biventricular Pacemakers: Comparison with Normals
2007
Catheter ablation of electrical storm
2011
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment
2011
Cryoballoon Ablation of Pulmonary Veins for Paroxysmal Atrial Fibrillation
2013
Association Between C-Reactive Protein and Recurrence of Atrial Fibrillation After Successful Electrical Cardioversion
2007
Ranolazine: Electrophysiologic Effect, Efficacy, and Safety in Patients with Cardiac Arrhythmias
2016
Fully integrated wearable sensor arrays for multiplexed in situ perspiration analysis
2016 StandoutNature
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
2010 Standout
Quality of Life in Patients with Atrial Fibrillation: A Systematic Review
2006
Clinical Outcomes of Catheter Substrate Ablation for High-Risk Patients With Atrial Fibrillation
2008
Long-Term Efficacy of Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
2007
Perioperative Management of Antithrombotic Therapy
2012 Standout
Long‐Term Outcome of Atrial Fibrillation Ablation: Impact and Predictors of Very Late Recurrence
2010
New Magnetic Resonance Imaging-Based Method for Defining the Extent of Left Atrial Wall Injury After the Ablation of Atrial Fibrillation
2008
Pulsed Field Ablation for Pulmonary Vein Isolation in Atrial Fibrillation
2019 Standout
The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA-PAF) Trial: clinical rationale, study design, and implementation
2009
Long-Term Quality of Life After Ablation of Atrial Fibrillation
2010
HRS Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated With Cardiac Sarcoidosis
2014 Standout
Efficacy and safety of catheter ablation versus antiarrhythmic drugs for atrial fibrillation: a meta-analysis of randomized trials
2010
Catheter ablation for atrial fibrillation: Should it be first-line therapy?
2007
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
2012
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Meta-Analysis of the Effectiveness and Safety of Catheter Ablation of Atrial Fibrillation in Patients With Versus Without Left Ventricular Systolic Dysfunction
2010
Time to recurrence of atrial fibrillation influences outcome following catheter ablation
2012
Efficacy of catheter ablation of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy
2006
Modeling the human Na<sub>v</sub>1.5 sodium channel: structural and mechanistic insights of ion permeation and drug blockade
2017 StandoutNobel
Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study)
2013
Distribution of Successful Ablation Sites of Idiopathic Right Ventricular Outflow Tract Tachycardia
2009
Radiofrequency Ablation as Initial Therapy in Paroxysmal Atrial Fibrillation
2012
Catheter ablation of fatal ventricular tachyarrhythmias storm in acute coronary syndrome—role of Purkinje fiber network
2009
Surgery for Paroxysmal Atrial Fibrillation in the Setting of Mitral Valve Disease: A Role for Pulmonary Vein Isolation?
2005
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study)†
2005
Outcomes After Cardioversion and Atrial Fibrillation Ablation in Patients Treated With Rivaroxaban and Warfarin in the ROCKET AF Trial
2013
Treatment of Atrial Fibrillation by the Ablation of Localized Sources
2012
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Rationale and current perspective for early rhythm control therapy in atrial fibrillation
2011
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Substrate-guided ablation of haemodynamically tolerated and untolerated ventricular tachycardia in patients with structural heart disease: effect of cardiomyopathy type and acute success on long-term outcome
2014
Executive Summary
2012 Standout
Atrial fibrillation
2011
Different Forms of Ventricular Tachycardia Involving the Left Anterior Fascicle in Nonischemic Cardiomyopathy: Critical Sites of the Reentrant Circuit in Low‐Voltage Areas
2009
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
2009 Standout
Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations
2018 Standout
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
2007
EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: Developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA)
2009
Obesity and Cardiovascular Disease
2009 Standout
A Systematic Review of Randomized Trials Comparing Radiofrequency Ablation with Antiarrhythmic Medications in Patients with Atrial Fibrillation
2008
Procedural Complications, Rehospitalizations, and Repeat Procedures After Catheter Ablation for Atrial Fibrillation
2012
Approach to the Catheter Ablation Technique of Paroxysmal and Persistent Atrial Fibrillation: A Meta-Analysis of the Randomized Controlled Trials
2011
Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
2014 Standout
Aggressive Risk Factor Reduction Study for Atrial Fibrillation and Implications for the Outcome of Ablation
2014
Catheter Ablation for Atrial Fibrillation in Congestive Heart Failure
2004
Catheter Ablation for Atrial Fibrillation in Heart Failure Patients
2015
A Randomized Trial to Assess Catheter Ablation Versus Rate Control in the Management of Persistent Atrial Fibrillation in Heart Failure
2013
Low vulnerability of the right phrenic nerve to electroporation ablation
2015
Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode
2007
Continuation of Amiodarone Therapy Despite Type II Amiodarone-Induced Thyrotoxicosis
2006
Conflicts of Interest in Cardiovascular Clinical Practice Guidelines
2011 Standout
Catheter Ablation Versus Medical Rate Control in Atrial Fibrillation and Systolic Dysfunction
2017
Catheter Ablation of Electrical Storm in a Collaborative Hospital Network
2011
Antiarrhythmic Drugs for Maintaining Sinus Rhythm After Cardioversion of Atrial Fibrillation
2006
Atrial Fibrillation Ablation: Reaching the Mainstream
2006
Feasibility and Safety of Dabigatran Versus Warfarin for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation
2012
Drug‐Induced QT‐Interval Prolongation: Considerations for Clinicians
2010
Antithrombotic Therapy for Atrial Fibrillation
2012
Management of atrial fibrillation in patients with heart failure
2006
Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation
2010
Reversal of Left Ventricular Dysfunction Following Ablation of Atrial Fibrillation
2006
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
2016 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
[Guidelines for the management of patients with atrial fibrillation. Executive summary].
2006
Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation
2009 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Combined Endocardial and Epicardial Catheter Ablation in Arrhythmogenic Right Ventricular Dysplasia Incorporating Scar Dechanneling Technique
2011
EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias
2009
Outcomes of Catheter Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
2012
Ballistocardiography and Seismocardiography: A Review of Recent Advances
2014 Standout
Incidence of postoperative atrial fibrillation recurrence in patients discharged in sinus rhythm after cardiac surgery: a systematic review and meta-analysis†
2017
Very Low Risk of Thromboembolic Events in Patients Undergoing Successful Catheter Ablation of Atrial Fibrillation With a CHADS 2 Score ≤3
2011
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2019 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Success of Ablation for Atrial Fibrillation in Isolated Left Ventricular Diastolic Dysfunction
2011
Long-Term Outcomes After Catheter Ablation of Cavo-Tricuspid Isthmus Dependent Atrial Flutter
2009
Guidelines for the Primary Prevention of Stroke
2014 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
Hydrogel bioelectronics
2018 Standout
Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score
2013
Atrial Fibrillation Ablation in Patients With Therapeutic International Normalized Ratio
2007
Systematic Review: Comparative Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation
2009
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation (RAAFT-2)
2014
Atrial Fibrillation and Heart Failure
2009
Lab-on-Skin: A Review of Flexible and Stretchable Electronics for Wearable Health Monitoring
2017 Standout
2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline)
2010
Treatment of Atrial Fibrillation With Antiarrhythmic Drugs or Radiofrequency Ablation
2009
Worldwide Epidemiology of Atrial Fibrillation
2013 Standout
Catheter ablation of arrhythmic storm triggered by monomorphic ectopic beats in patients with coronary artery disease
2009
Long-Term Results of Catheter Ablation in Paroxysmal Atrial Fibrillation
2010
Implantable Cardioverter Defibrillators in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
2013
Stretchable, Skin‐Mountable, and Wearable Strain Sensors and Their Potential Applications: A Review
2016 Standout
Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation
2015
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary
2006
Risk of Atrial Fibrillation After Atrial Flutter Ablation: Impact of AF History, Gender, and Antiarrhythmic Drug Medication
2014
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
2015
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2006
Catheter Ablation for Atrial Fibrillation with Heart Failure
2018
Prevention of stroke in patients with atrial fibrillation: current strategies and future directions
2008
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Pulmonary Vein Isolation for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation
2009
Atrial fibrillation: cure or treat?
2009
Flexible and Stretchable Electronics for Biointegrated Devices
2012
25th Anniversary Article: The Evolution of Electronic Skin (E‐Skin): A Brief History, Design Considerations, and Recent Progress
2013 Standout
Works of Antonio Rossillo being referenced
The Risk of Thromboembolism and Need for Oral Anticoagulation After Successful Atrial Fibrillation Ablation
2010
Embolic Events and Char Formation During Pulmonary Vein Isolation in Patients with Atrial Fibrillation: Impact of Different Anticoagulation Regimens and Importance of Intracardiac Echo Imaging
2005
Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents
2004
Efficacy, Safety, and Outcome of Atrial Fibrillation Ablation in Septuagenarians
2008
Role of anticoagulation therapy after pulmonary vein antrum isolation for atrial fibrillation treatment
2008
Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function
2004
Response to Pharmacological Challenge of Dissociated Pulmonary Vein Rhythm
2005
Fragmented and delayed electrograms within fibrofatty scar predict arrhythmic events in arrhythmogenic right ventricular cardiomyopathy: Results from a prospective risk stratification study
2012
Transcranial Doppler Detection of Microembolic Signals During Pulmonary Vein Antrum Isolation: Implications for Titration of Radiofrequency Energy
2006
Impact of Coronary Sinus Lead Position on Biventricular Pacing:
2004
Clinical predictors and relationship between early and late atrial tachyarrhythmias after pulmonary vein antrum isolation
2008
Radiofrequency Ablation vs Antiarrhythmic Drugs as First-line Treatment of Symptomatic Atrial Fibrillation
2005
Mode of initiation and ablation of ventricular fibrillation storms in patients with ischemic cardiomyopathy
2004
Incidence of Atrial Fibrillation Post‐Cavotricuspid Isthmus Ablation in Patients with Typical Atrial Flutter: Left‐Atrial Size as an Independent Predictor of Atrial Fibrillation Recurrence
2007
Impact of Age on the Outcome of Pulmonary Vein Isolation for Atrial Fibrillation Using Circular Mapping Technique and Cooled‐Tip Ablation Catheter:
2004
Pulmonary vein antrum isolation for treatment of atrial fibrillation in patients with valvular heart disease or prior open heart surgery
2004
Phrenic Nerve Injury After Catheter Ablation: Should We Worry About This Complication?
2006
Short- and Long-Term Success of Substrate-Based Mapping and Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Dysplasia
2005
828-3 Chronic cure rate after pulmonary vein isolation in patients with nonparoxysmal atrial fibrillation: Impact of a second ablation
2004
Improving Atrial Fibrillation Detection in Patients with Implantable Cardiac Devices by Means of a Remote Monitoring and Management Application
2014
Visually-Guided Balloon Catheter Ablation of Atrial Fibrillation
2009
A Randomized Controlled Trial of the Efficacy and Safety of Electroanatomic Circumferential Pulmonary Vein Ablation Supplemented by Ablation of Complex Fractionated Atrial Electrograms Versus Potential-Guided Pulmonary Vein Antrum Isolation Guided by Intracardiac Ultrasound
2009